SPY416.07+3.90 0.95%
DIA341.30+3.18 0.94%
IXIC13,950.22+163.95 1.19%

Rubius Therapeutics: Any Leftover Proceeds to Be Used for General Corporate Purposes

Rubius Therapeutics: Any Leftover Proceeds to Be Used for General Corporate Purposes

· 03/16/2021 21:34

Please log in to view news